Medytox, "MFDS 'Medytoxyn' Product Approval Notification Not Yet Received"
[Asia Economy Reporter Eunmo Koo] Medytox stated on the 18th regarding the news about the cancellation of the product approval for the botulinum toxin product ‘Medytoxine’ that “the company has not yet received the disposition notice from the Ministry of Food and Drug Safety,” and “we will re-disclose when specific details such as receipt of the disposition notice from the Daejeon Food and Drug Administration, the disposition authority, are confirmed.”
Hot Picks Today
!["Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"](https://cwcontent.asiae.co.kr/asiaresize/93/2026051507261063923_1778797570.png)
"Not Everyone Can Afford This: Inside the World of the True Top 0.1% [Luxury World]"
- While Everyone Focused on Samsung and Nix, This Company Soared 50%... Hit Record Highs for 4 Days [Weekend Money]
- "Plunged During the War, Now Surging Again"... The Real Reason Behind the 6% One-Day Silver Market Rally [Weekend Money]
- Incoming Fed Chairman Kevin Walsh to Sell $2.52 Million Worth of Coupang Shares
- "Target Price Set at 970,000 Won"... Top Investors Already Watching, Only an 'Uptrend' Remains [Weekend Money]
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
